Want a career in science? Good at maths? Bioinformatics needs you!
05 August, 2010 by Tim DeanThe staggering amounts of data being generated in genomics, epigenomics, proteomics and other ‘omics studies - not to mention systems biology, which attempts to knit the various ‘omics together - is presenting a titanic challenge for life science researchers.
WEHI receives $450,000 from VCA
05 August, 2010 by Staff WritersThe Walter and Eliza Hall Institute (WEHI) has received grants totalling $450,000 from the Victorian Cancer Agency to support its research into BH3 mimetics cancer drugs and the creation of an information sharing portal focussed on rare cancers.
Patrys to receive funding of $15 million
03 August, 2010 by David BinningMelbourne biotech Patrys announced today that it has secured funding of up to $15 million over the next three years to develop its lead natural human anti-body candidates into treatments for various cancers.
Sigma names Jeff Sells as company CFO
28 July, 2010 by David BinningBeleaguered Victorian biotech Sigma Pharmaceuticals has appointed former group treasurer Jeff Sells as its new CFO.
Young 2010 Garvan Fellows named
27 July, 2010 by Staff WritersThe Garvan Institute has named two of its top upcoming scientists as Young 2010 Garvan Fellows with each to receive a grant of $25,000 to advance their research looking into treatments for cancer and diabetes.
How music makes you smarter
19 July, 2010 by Staff WritersMusic training may bring about biological changes in the brain that could enhance music processing and even transfer to other domains.
Australia to host 19th World Congress of Soil Science
16 July, 2010 by Staff WritersMore than 2000 of the world’s leading experts on soil will converge on Brisbane next month for the 19th World Congress of Soil Science.
Life Sciences sector down for Q4 but ahead of wider market: PWC
15 July, 2010 by David BinningPricewaterhouseCoopers has released its BioForum report for the fourth quarter FY10 showing a fall of 9.5 percent for the local Life Sciences Index, which performed slightly better than the broader market.
Sigma rejects revised offer from Aspen
12 July, 2010 by Staff WritersMelbourne biotech Sigma Pharmaceuticals has assured shareholders that it is trying to negotiate a better deal than the revised $0.55 a share offered for the company by South African generics producer Aspen Pharmacare Holdings.
Lack of R&D output a worrying sign for big pharma
02 July, 2010 by Staff WritersPharmaceutical companies continue to be heavily reliant on sales form their mature drugs, while investment in R&D and clinical trials for their successors has shown a marked decline.
Sydney research centre to nurture U.S approaches to innovation
02 July, 2010 by Staff WritersMerck has stumped up $500,000 to fund a new research centre at the University of Sydney designed to help Australia benefit from U.S approaches to innovation.
Majors help deliver strong quarter for Australian life sciences: PWC
02 July, 2010 by Staff WritersPrice Waterhouse Coopers has released its quarterly Bioforum report showing that the Australian life sciences sector is outperforming the wider market despite a fairly slow start to the year.
MP Biomedicals buys NZ’s ICPBio
29 June, 2010 by David BinningCalifornia’s MP Biomedicals has acquired the assets of Auckland-based protein biologics manufacturing company ICPbio in deal estimated to be worth.
Government seeking to apply R&D Tax Credit retrospectively from July 1 this year
29 June, 2010 by David BinningFederal innovation minister Kim Carr has affirmed that the government will seek to have its new R&D Tax Credit apply retrospectively from July 1 this year.
Roundtable: from innovation to commercialisation - Part III: closing comments
28 June, 2010 by Tim DeanIn this final part of the roundtable discussion the panellists address the role of government in commercialisation and then provide their closing comments on how we can improve the system in Australia.
